Headaches occur in about 10% to 15% of users, most commonly during the first two weeks
Each patient underwent baseline laboratory testing, including a standard oral glucose tolerance test (OGTT) following a 12 h fast, with measurements of both glucose and insulin levels
Novo Nordisk, a competitor to Eli Lilly, has already sought FDA approval for an oral semaglutide pill, its oral GLP-1 pill, and is expected to receive a decision by the end of this year
However, in the AWARD 7 trial, a dedicated 52-week trial of dulaglutide in patients with diabetic kidney disease, stage 3-4, the decline with time was significantly reduced compared with insulin glargine [29]
Comparing Costs of New Weight Loss Medications The cost of new weight loss medications can be a significant barrier for many individuals
There are currently 5-10 million people on a branded GLP-1 medication, but there is an estimated 50-60 million who are clinically eligible to receive Wegovy and have insurance coverage for it, and of those, millions could purchase it for a copay of less than $100/month
